Publication Beamlines Strategic Pillar
Heide, Fabian; McDougall, Matthew; Harder-Viddal, Candice; Roshko, Roy; Davidson, David et al. (2021). Boron rich nanotube drug carrier system is suited for boron neutron capture therapy. Scientific Reports 11(1) . 10.1038/s41598-021-95044-0. CMCF, CMCF-ID Health
Grochulski, Pawel; Labiuk, Shaunivan (2021). Review of health research at the Canadian Light Source. Nuclear Instruments and Methods in Physics Research. Section B: Beam Interactions with Materials and Atoms 499, 70-76. 10.1016/j.nimb.2021.05.003. BIOXAS, BMIT, CMCF, MID-IR, SM, SXRMB, VESPERS Health
Daniel-Ivad, Phillip; Ryan, Katherine S. (2024). Structure of methyltransferase RedM that forms the dimethylpyrrolinium of the bisindole reductasporine. Journal of Biological Chemistry 300(1) , 105520. 10.1016/j.jbc.2023.105520. CMCF Health
Summers, Kelly L; Dolgova, Natalia V; Gagnon, Kenneth B; Sopasis, George J; James, Ashley K et al. (2020). PBT2 acts through a different mechanism of action than other 8-hydroxyquinolines: an X-ray fluorescence imaging study. Metallomics 12(12) , 1979-1994. 10.1039/d0mt00222d. CLS-APS Health
Simpson, R.; Varney, T. L.; Swanston, T.; Coulthard, I.; Cooper, D. M. L. et al. (2019). Investigating Past Lead Exposure in Bioarchaeological Remains with Synchrotron X-ray Fluorescence and Absorption Spectroscopy. Synchrotron Radiation News 32(6) , 11-16. 10.1080/08940886.2019.1680209. CLS-APS Health
Kaur, Gurnit; Ponomarenko, Olena; Zhou, Janet R.; Swanlund, Diane P.; Summers, Kelly L. et al. (2020). Studies of selenium and arsenic mutual protection in human HepG2 cells. Chemico-Biological Interactions 327, 109162. 10.1016/j.cbi.2020.109162. CLS-APS Health
James, Ashley K.; Dolgova, Natalia V.; Nehzati, Susan; Korbas, Malgorzata; Cotelesage, Julien J. H. et al. (2022). Molecular Fates of Organometallic Mercury in Human Brain. ACS Chemical Neuroscience 13(12) , 1756-1768. 10.1021/acschemneuro.2c00166. CLS-APS Health
Kaduk, James; Dosen, Anja; Blanton, Tom (2025). Crystal structure of anisomycin, C 14 H 19 NO 4 . Powder Diffraction , 1-6. 10.1017/s0885715625100791. BXDS-WLE Health
Kaduk, James A.; Dosen, Anja; Blanton, Tom N. (2025). Powder pattern and hydrogen bonding in the crystal structure of phenelzine sulfate, C 8 H 14 N 2 (SO 4 ). Powder Diffraction , 1-5. 10.1017/s0885715625000545. BXDS-WLE Health
Kaduk, James A.; Dosen, Anja; Blanton, Tom N. (2025). Crystal structure of niraparib tosylate monohydrate Form I, (C 19 H 21 N 4 O)(C 7 H 7 O 3 S)(H 2 O). Powder Diffraction , 1-9. 10.1017/s0885715625000181. BXDS-WLE Health
Kaduk, James A.; Dosen, Anja; Blanton, Tom N. (2025). Crystal structure of ethynodiol diacetate, C 24 H 32 O 4 . Powder Diffraction , 1-6. 10.1017/s0885715625100729. BXDS-WLE Health
Kaduk, James A.; Dosen, Anja; Blanton, Tom N. (2025). Crystal structure of trametinib dimethyl sulfoxide, C26H23FIN5O4(C2H6OS). Powder Diffraction 40(2) , 162-167. 10.1017/s0885715625000168. BXDS-WLE Health
Kaduk, James A.; Dosen, Anja; Blanton, Tom N. (2025). Crystal structure of aprocitentan Form A, C16H14Br2N6O4S. Powder Diffraction 40(2) , 168-174. 10.1017/s088571562500017x. BXDS-WLE Health
Kaduk, James A.; Dosen, Anja; Blanton, Tom (2025). Crystal structure of repotrectinib, C18H18FN5O2. Powder Diffraction , 1-6. 10.1017/s0885715625100882. BXDS-WLE Health
Kaduk, James A.; Dosen, Anja; Blanton, Tom (2025). Crystal structure of palovarotene, C 27 H 30 N 2 O 2 . Powder Diffraction , 1-6. 10.1017/s0885715625100869. BXDS-WLE Health